Month: September 2021
COLLINGWOOD, Ontario, Sept. 21, 2021 (GLOBE NEWSWIRE) — The Limestone Boat Company Limited (“Limestone”) (TSXV: BOAT) – owner and builder of Aquasport Boats, Limestone® Boats and Boca Bay Boats – is pleased to announce its participation in the Benzinga Electric Vehicle Conference (“the Conference”), taking place virtually on Wednesday, September 22, 2021.
Limestone CEO Scott Hanson will present the Company’s landmark partnership with Vision Marine Technologies (NASDAQ: VMAR) and will discuss how the 35-year old heritage boat company known for its timeless design, smooth ride, and reliability intends to move forward by offering its customers unprecedented power and torque in an electric outboard with Vision’s E-motion 180, which boasts 180 horsepower and is expected to deliver run times and cruising speeds that parallel the boating...
Oma Savings Bank Plc – Acquisition of own shares on 21 September 2021
Written by Customer Service on . Posted in Public Companies.
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 21 SEPTEMBER 2021 AT 20.15 P.M. EET, CHANGES IN COMPANY’S OWN SHARESOma Savings Bank Plc – Acquisition of own shares on 21 September 2021
At Nasdaq Helsinki Ltd (XHEL):
Date: 21.9.2021Exchange transaction: BuyShare trading code: Oma Savings Bank Plc (OMASP)Amount, shares: 8,000Total cost, EUR: 123,391.20Average price/share, EUR: 15.4239Highest price/share, EUR: 15.55Lowest price/share, EUR: 15.10
The company holds a total of 56,700 of its own shares (OMASP) including the shares acquired on 21 September 2021.
Detailed information concerning the acquisition is attached to this stock exchange release.On behalf of Oma Savings Bank Plc
Nordea Bank Oyj
Janne Sarvikivi Sami HuttunenFurther information:Sarianna Liiri, CFO, tel +358 40 835 6712, sarianna.liiri@omasp.fiMinna Sillanpää, CCO,...
AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today
Written by Customer Service on . Posted in Public Companies.
Company to begin trading on Nasdaq under new ticker symbol, “FBWI”, effective September 22
BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that it will begin operating under its new corporate name, First Wave BioPharma, Inc., effective today upon the completion of certain filings with the Delaware Secretary of State. The Company’s common shares will commence trading on the Nasdaq Capital Market under the new ticker symbol “FWBI” and CUSIP number (33749P101) at the market open on September 22, 2021.Formerly known as AzurRx BioPharma, Inc., the Company previously announced that it would rename...
Hydrogen Energy Storage Market worth USD 27.18 billion by 2028, registering a CAGR of 8.50% – Report by Market Research Future (MRFR)
Written by Customer Service on . Posted in Mergers And Acquisitions.
New York, Sept. 21, 2021 (GLOBE NEWSWIRE) — Hydrogen Energy Storage Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Hydrogen Energy Storage Market Research Report, Technology, End-User and Region – Forecast till 2028” the market size is projected to be worth USD 27.18 billion by 2028, registering a CAGR of 8.50% during the forecast period (2021 – 2028)., The market was valued at USD 16.53 billion in 2021.
Competitive Analysis
List of the Key Companies Profiled in the Hydrogen Energy Storage Market Research Report are –Hbank Technologies Inc.
Inoxcva
VRV S.P.A
Luxfer Holdings PLC
Worthington Industries Inc.
Mcphy Energy S.A
Linde AG.
Air Liquide
Praxair Inc
others. Get Free Sample PDF Brochure
https://www.marketresearchfuture.com/sample_request/7216
Manufacturers...
NFL BIOSCIENCES: approval for its patent to be granted in the United States
Written by Customer Service on . Posted in Public Companies.
NFL BIOSCIENCES: approval for its patent to be granted in the United States
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that the United States Patent and Trademark Office (USPTO) issued, on September 21 with number US 11123395, the patent for NFL-101, a nicotine-free botanical drug candidate comprising natural proteins extracted from tobacco leaves, focused primarily on smoking cessation. This patent protects the innovation that NFL-101 is based on through to 2036 in the United States.
NFL Biosciences has adopted a knowledge management and protection strategy that led it to submit two patent families granting it exclusive rights to its drug candidate NFL-101. This product patent, initially registered in France and approved...
CREDIT AGRICOLE SA: End of Crédit Agricole S.A.’s 558.6 million euros share repurchase program
Written by Customer Service on . Posted in Public Companies.
Montrouge, 21 september 2021
End of Crédit Agricole S.A.’s558.6 million euros share repurchase program
Crédit Agricole S.A.’s share repurchase program, which started on 10 June 2021 was fully completed on 21 September 2021.
As of 21 September 2021, 47,616,752 ordinary shares in the share capital of Crédit Agricole S.A. were purchased under the irrevocable instruction given to an independent investment services provider, for an aggregate purchase price of 558.6 million euros, corresponding to the maximum consideration of the share repurchase program. Such irrevocable instruction was therefore terminated as of the same date.
As previously announced, the shares purchased in the context of this share repurchase program will be cancelled.
CONTACT PRESSE CRÉDIT AGRICOLE
Charlotte de Chavagnac : 01 57 72 11 17 – charlotte.dechavagnac@credit-agricole-sa.fr
...
Buchanan Technologies Acquires Cybernoor to Expand Managed Service Offerings
Written by Customer Service on . Posted in Mergers And Acquisitions.
MISSISSAUGA, Ontario, Sept. 21, 2021 (GLOBE NEWSWIRE) — Buchanan Technologies, a leading managed IT services provider, has announced today that they have acquired Cybernoor, an expert in Oracle application performance management solutions.
Founded in 2007, Cybernoor is a top global provider of Oracle platform solutions and serves customers with some of the largest Oracle implementations in the world. Cybernoor has been recognized by Oracle Corporation as a driving force in the creation of innovative technology solutions and featured in Oracle Magazine as a leader in applications performance optimization.
“This partnership allows us to expand our services to better meet the needs of today’s modern organizations, including many of Buchanan’s enterprise customers who are already leveraging the Oracle platform,” said James Buchanan,...
Buchanan Technologies Acquires Cybernoor to Expand Managed Service Offerings
Written by Customer Service on . Posted in Mergers And Acquisitions.
GRAPEVINE, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) — Buchanan Technologies, a leading managed IT services provider, has announced today that they have acquired Cybernoor, an expert in Oracle application performance management solutions.
Founded in 2007, Cybernoor is a top global provider of Oracle platform solutions and serves customers with some of the largest Oracle implementations in the world. Cybernoor has been recognized by Oracle Corporation as a driving force in the creation of innovative technology solutions and featured in Oracle Magazine as a leader in applications performance optimization.
“This partnership allows us to expand our services to better meet the needs of today’s modern organizations, including many of Buchanan’s enterprise customers who are already leveraging the Oracle platform,” said James Buchanan, Founder...
OSE Immunotherapeutics Announces H1 2021 Results and Provides a Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Positive final Phase 3 results for Tedopi® in non-small cell lung cancer (NSCLC) after ICI failure.
Positive Phase 1 dose escalation results for BI 765063 (CD47/SIRPα pathway) as monotherapy or in combination with ezabenlimab (anti-PD-1) in advanced solid tumor patients.
Initiation of two Phase 2 trials with OSE-127/S95011 in Sjögren’s syndrome (Servier sponsor) and in ulcerative colitis (OSE sponsor).
Initiation of two Phase 2 studies with Tedopi® in combination with ICI in NSCLC and in ovarian cancer in collaboration with oncology expert groups.
Global license agreement entered with Veloxis for FR104 in transplant indications for up to €315 million.
Strong non-dilutive financing including €11 million upfront/milestone payments and €6.9 million public fundings.
€9 million turnover and €27.3 million available cash as of June 30,...
Tecan issues CHF 250 million inaugural straight bond
Written by Customer Service on . Posted in Public Companies.
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules
Männedorf, Switzerland – September 21, 2021 – Today, the Tecan Group (SIX Swiss Exchange: TECN) successfully raised CHF 250 million debt through the issuance of a fixed rate domestic straight bond. The bonds bear a 0.050% coupon and have a duration of 4 years (final maturity October 6, 2025). Settlement date of the bonds is October 6, 2021. The bonds will be listed and traded on the SIX Swiss Exchange.
The net proceeds of the issue will partly refinance the USD 1.0 billion (CHF 920 million) acquisition of Paramit Corporation, a leading...
